StaphAseptic First Aid Bactericide Gel
Helps prevent skin infections caused by antibiotic resistant staph (MRSA) and other germs.
 

 
 
 
 
 
 
 
 


 
Product Info for Safety Officers

 

StaphAseptic® First Aid Antiseptic/Pain Relieving Gel

StaphAseptic®

StaphAseptic®

Protect your crew from skin infections…

Antibiotic resistant germs including methicillin resistant staph (MRSA) are a growing concern because they spread easily from person to person and are appearing at epidemic rates. MRSA can spread quickly from:

  • close skin-to-skin contact
  • cuts in the skin
  • contaminated surfaces and equipment
  • poor personal hygiene

30%-50% of the population carries staph germs in their nose.  Once in contact with an open wound, these germs can turn into a serious infection that is very difficult and expensive to treat.

Commonly used topical antibiotics, including popular triple antibiotics, have not been shown to prevent MRSA infections and can cause skin irritation in nearly 10% of the population.  In vitro studies have shown that StaphAseptic® kills over 99.9% of MRSA germs, preventing an infection without antibiotics.  This new pain-relieving wound treatment should be used as part of a complete staph prevention program to protect your workers from skin infections.

Educate your workers about MRSA and how to prevent skin infections. Download a copy of our Facts About MRSA guide.

Be sure to have your workers consult a physician for any active infections. Staph bacteria, including MRSA, can cause skin infections that may look like a pimple, boil or ingrown hair and can be red, swollen, painful, or have pus and other drainage. Serious infections may cause pneumonia, bloodstream infections, or even death.

Contact us for samples.

To view MRSA test results (PDF), click here.

Sizes available:

  • 2 oz tube                    
  • 144 ct. dispenser box             


TecLabs® HOME | PRODUCT INFORMATION | MRSA FAQ | NEWS | WHERE TO BUY | CONTACT US | SITE MAP
Tec Laboratories Inc., 1-800-482-4464

Website design by Feynman Group